Page last updated: 2024-11-01
nialamide and Leprosy
nialamide has been researched along with Leprosy in 1 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
Leprosy: A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| BARBA RUBIO, M | 1 |
| PEREZ SUAREZ, G | 1 |
Other Studies
1 other study available for nialamide and Leprosy
| Article | Year |
|---|---|
[P-1133 (nialamide) as treatment of the leprous reaction].
Topics: Hydrazines; Leprosy; Nialamide | 1960 |